DoW Bone Marrow Failure, Idea Development Award
This grant supports innovative research ideas from both established and early-career investigators to advance understanding and treatment of bone marrow failure, without requiring preliminary data.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 5, 2026: Pre-Application | November 4, 2026: Full Application | November 12, 2026: End of Application Verification Period
Funding Amounts: Up to $800,000 total costs per award (max 3 years); ~$4M total program funds; ~5 awards expected.
Summary: Supports innovative, high-impact research to advance the understanding and cure of bone marrow failure (BMF) diseases; open to both established and early-career investigators.
Description
This opportunity supports research that advances the vision of understanding and curing inherited or acquired bone marrow failure (BMF) diseases. The program encourages innovative, hypothesis-driven projects that address critical gaps in BMF research, including studies on disease mechanisms, prevention, and treatment. Both established investigators (EIs) and early-career investigators (ECIs) are eligible, with tailored review criteria for each. Preliminary data are not required, and the program is open to a broad range of organizations and investigators.
Projects must focus on BMF diseases and may include correlative studies associated with clinical trials or clinical samples, but funding for the clinical trial itself is outside the scope. Applications addressing myeloproliferative neoplasms, leukemia, or other malignancies as the primary focus are not eligible.
